Immunotherapy is reshaping cancer treatment paradigms; however, response rates to immune therapies are low and depend on the host's pre-existing antitumor immunity. The tumor microenvironment is comprised of malignant cells, stroma, and extracellular molecules and can hinder immune control of tumors. Herein, we review how anti-tumor immune responses are formed and how tumors avoid immune…
Advances in Radiation Oncology Template
Write in a clean editor, then format for Advances in Radiation Oncology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Advances in Radiation Oncology format
Advances in Radiation Oncology is a peer-reviewed journal published by Elsevier, covering Advanced Radiotherapy Techniques, Advances in Oncology and Radiotherapy, Effects of Radiation Exposure.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Advances in Radiation Oncology 12 (2023) 45–58.
Formats any DOI in Advances in Radiation Oncology style. No sign-up. |
| Publishes research in | Advanced Radiotherapy Techniques Advances in Oncology and Radiotherapy Effects of Radiation Exposure Prostate Cancer Diagnosis and Treatment Management of metastatic bone disease |
| ISSN | 2452-1094 |
| Citation impact (2-yr) | 1.54 |
| h-index | 51 |
| i10-index | 598 |
| Total citations | 18,630 |
| Article processing charge | $2,000 |
| Open access | Yes |
| Top institutions publishing here | The University of Texas MD Anderson Cancer Center |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Advances in Radiation Oncology per year
Citation impact of Advances in Radiation Oncology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Advances in Radiation Oncology
PURPOSE: Stereotactic body radiation therapy (SBRT) is an effective treatment for oligometastatic or unresectable primary malignancies, although target proximity to organs at risk (OARs) within the ultracentral thorax (UCT) limits safe delivery of an ablative dose. Stereotactic magnetic resonance (MR)-guided online adaptive radiation therapy (SMART) may improve the therapeutic ratio using reoptimization to account for…
PURPOSE: Radiation-induced lymphopenia (RIL) is the result of direct toxicity to circulating lymphocytes as they traverse the irradiated field, occurs in 40% to 70% of patients who undergo conventional external beam radiation therapy, and is associated with worse outcomes in multiple solid tumors. As immunotherapy strategies evolve, a better understanding of radiation's effects on the…
PURPOSE: During a global pandemic, the benefit of routine visits and treatment of patients with cancer must be weighed against the risks to patients, staff, and society. Prostate cancer is one of the most common cancers radiation oncology departments treat, and efficient resource utilization is essential in the setting of a pandemic. Herein, we aim…
PURPOSE: Daily magnetic resonance (MR)-guided radiation has the potential to improve stereotactic body radiation therapy (SBRT) for tumors of the liver. Magnetic resonance imaging (MRI) introduces unique variables that are untested clinically: electron return effect, MRI geometric distortion, MRI to radiation therapy isocenter uncertainty, multileaf collimator position error, and uncertainties with voxel size and tracking.…